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The remarkable plasticity of Schwann cells allows them to adopt the Remak (non-
myelin) and myelin phenotypes, which are specialized to meet the needs of small and
large diameter axons, and differ markedly from each other. It also enables Schwann
cells initially to mount a strikingly adaptive response to nerve injury and to promote
regeneration by converting to a repair-promoting phenotype. These repair cells activate
a sequence of supportive functions that engineer myelin clearance, prevent neuronal
death, and help axon growth and guidance. Eventually, this response runs out of steam,
however, because in the long run the phenotype of repair cells is unstable and their
survival is compromised. The re-programming of Remak and myelin cells to repair
cells, together with the injury-induced switch of peripheral neurons to a growth mode,
gives peripheral nerves their strong regenerative potential. But it remains a challenge
to harness this potential and devise effective treatments that maintain the initial repair
capacity of peripheral nerves for the extended periods typically required for nerve repair
in humans.
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INTRODUCTION: OVERVIEW OF SCHWANN CELLS AND NERVE
INJURY
Examination of the Schwann cells in uninjured nerves shows two surprisingly different cell types.
One of them is the rather inconspicuous Remak cell, or non-myelin Schwann cell. These cells
envelop all the small diameter axons, including many sensory axons and the all-important axons
of the autonomic nervous system. The axons lie in troughs along the cell surface, and in rodents
each cell generally ensheaths several axons, although in human nerves, one axon per Remak cell
is common. The larger axons, including some sensory axons and the axons of motor neurons, are
wrapped by myelin Schwann cells. They are 2–3 times longer that Remak cells and much bulkier,
containing the myelin sheath, which is formed by the Schwann cell membrane wrapping multiple
times around the axon and condensing to form a compact myelin cuff around the axon.
Both Remak and myelin cells are coated by a basal lamina, outside of which lies the connective
tissue, the endoneurium, which contains fibroblasts, blood vessels and a few macrophages and is
ultimately surrounded by a multi-layered cellular tube, the perineurium (Figure 1). This assembly
is termed a fascicle. Small nerves are uni-fascicular, while large nerves contain many fascicles bound
together by connective tissue, the epineurium.
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FIGURE 1 | Diagrammatic representation of uninjured and injured nerve. Each diagram shows one fascicle and its main cellular constituents. Red line: basal lamina
of Schwann cells (the basal lamina associated with perineurium and blood vessels is not shown), P, perineurium; R, Remak Schwann cell; M, myelin Schwann cell; F,
fibroblast; E the connective tissue of the endoneurium, Ma, macrophage; BB, Bungner band containing transverse profiles of several repair cells and surrounded by a
basal lamina.
While both Schwann cells are thought to provide axons with
metabolic and trophic support, only the myelin cells have the
key role of accelerating nerve impulse conduction. Remak and
myelin cells also express some common proteins, such as S100,
a classical Schwann cell marker, while at the same time each cell
possesses a characteristic molecular profile (reviewed in Jessen
and Mirsky, 2005, 2016; Glenn and Talbot, 2013; Brosius Lutz
and Barres, 2014; Monk et al., 2015). Thus, Remak cells express
several markers also found on developing Schwann cells, such
as neural cell adhesion molecule (NCAM), p75 neurotrophin
receptor (p75NTR) and glial fibrillary acidic protein (GFAP), and
L1 NCAM. The myelin cells on the other the hand express a
large range of molecules that relate to the synthesis, maintenance
or structure of the myelin sheath. This includes the major
pro-myelin transcription factor Egr2 (Krox20), high levels of the
enzymes that control cholesterol synthesis, structural proteins
such as myelin protein zero (MPZ) and myelin basic protein
(MBP), andmembrane associated proteins like myelin associated
glycoprotein (MAG), PMP22, and periaxin.
As different as Remak and myelin cells appear, these cells
nevertheless originate developmentally from a common cell, the
immature Schwann cell, present in rodent nerves in the perinatal
period (Figure 2). These cells, in turn, derive from a distinct
glial cell of embryonic nerves, the Schwann cell precursor.
The conversion of Schwann cell precursors to Schwann cells
is controlled by transcription factors such as AP2α, Zeb2,
and Notch, and extracellular signals including endothelin and
axon-associated neuregulin, which is essential for precursor
survival (reviewed in Jessen andMirsky, 2005; Jessen et al., 2015b;
Quintes and Brinkmann, 2017).
Schwann cell precursors unambiguously exhibit a glial
phenotype, expressing characteristic glial features, such as
ensheathing axons within nerves and expressing Schwann cell
associated mRNAs, such as those encoding for the major myelin
protein MPZ and desert hedgehog (Dhh). It is interesting,
however, that these cells also retain one notable feature of the
neural crest cells from which they originate, namely they have
a broad developmental potential. Thus, Schwann cell precursors
give rise to cells such as melanocytes, endoneurial fibroblasts
and neurons, in addition to Schwann cells, during embryonic
development (reviewed in Jessen et al., 2015b; Kastriti and
Adameyko, 2017).
One of the most interesting biological properties of Schwann
cells is their plasticity (reviewed in Boerboom et al., 2017;
Castelnovo et al., 2017; Jacob, 2017; Ma and Svaren, 2018).
The phenotype adopted by Schwann cells, such as the Remak
or myelin phenotypes described above, is strikingly dependent
on signals in the cellular environment. Thus, all the evidence
indicates that if a Remak cell was placed in contact with
large diameter axon it would adopt the myelin phenotype
and conversely, a myelin cell would convert to a Remak
cell if associated with small diameter axons. This phenotypic
instability may pre-dispose Schwann cells to demyelinating
disease, since myelin Schwann cells may regress from myelin
maintenance relatively easily in response to mutations that
disturb cellular homeostasis. After nerve damage, Schwann
cell plasticity and the ready response to environmental signals
initially helps to provide nerves with strong regenerative
potential, but at later times after injury, these features contribute
to regenerative failure, as repair supportive Schwann cells are
not sustained during the long times required for nerve repair in
humans.
After nerve injury, the Schwann cells distal to the damaged
area lose contact with axons as they degenerate. This represents
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FIGURE 2 | The main transitions in the Schwann cell lineage during development and after injury. Black uninterrupted arrows show normal development. Red
arrows show the Schwann cell injury response. Black stippled arrows show post-repair reformation of Remak and myelin cells (with permission from Jessen et al.,
2015b).
a radical change in the signaling environment, because key
signals for the control Schwann cell phenotype come from
axons. Subsequently, further change is provided by a cocktail of
bioactive factors secreted by macrophages, which invade injured
nerves in large numbers. In response to these perturbations,
Schwann cells show a remarkably fortunate response. This is
the conversion of Remak and myelin cells, within their original
basal lamina tubes, to a Schwann cell phenotype, the repair
Schwann cell, which is specialized to encourage regeneration
(reviewed in Jessen and Mirsky, 2016; Figure 2). These cells
execute a repair program, a partly overlapping sequence of
phenotypic changes involving myelin autophagy, expression of
cytokines that call in macrophages for later stages of myelin
clearance, activation of trophic factor expression and cellular
elongation and branching to form regeneration tracks, called
Bungner Bands. In this way, repair cells clear myelin, support
the survival of injured neurons, axon regeneration and target
innervation. These are the cells present in the distal stump of
injured nerves along which regenerating axons navigate after
injury, often for months or even years in humans due to the slow
rate of axon growth.
One of the main problems in human nerve repair is that
the phenotype of repair cells is not stable, but fades with time
as the cells fail to maintain expression of trophic factors that
promote axonal growth, likely due to gradual changes in the
signaling environment within the chronically denervated distal
stump (reviewed in Höke, 2006b; Sulaiman and Gordon, 2009).
Furthermore, the repair cell population is not stable, their
number eventually declining to very low levels. The reasons for
the deterioration of repair cells are poorly understood, although
the transcription factors STAT3 and c-Jun have been implicated
in this process.
Importantly, PNS neurons also respond to axonal damage
by activating an extensive gene program that facilitates axonal
regeneration, a response classically referred to as the cell body
response or the signaling to growth mode switch (Allodi et al.,
2012; Blesch et al., 2012; reviewed in Fu and Gordon, 1997;
Doron-Mandel et al., 2015).
Therefore, in response to damage, both neurons and Schwann
cells convert to cell states that are specialized to deal with
injury and promote healing. Comparable reprogramming of
differentiated cells in response to injury can also be seen
in other systems. This includes the conversion of fibroblasts
to myofibroblasts during wound healing, and of pigmented
epithelial cells to lens cells in the eye, the conversions of
supportive cells to hair cells in the ear, hepatocytes to biliary
epithelial cells in the liver, and of endocrine α to β cells in the
pancreatic isles. In all of these cases, differentiated cells change
identity in order to promote tissue homeostasis and repair.
This type of change has therefore been termed adaptive cellular
reprogramming (reviewed in Jessen et al., 2015a).
Eventually, axons that have successfully regenerated induce
ensheathing repair cells to adopt again the Remak and myelin
phenotypes, thereby restoring the nerve to its functional state.
The repair Schwann cells are therefore a transient population,
which exists only while they are needed.
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We will now discuss some of the issues aired above in more
detail.
THE SCHWANN CELL INJURY RESPONSE:
THE GENERATION OF REPAIR CELLS
Unfortunately, in humans most nerve injuries involve nerve
transection rather than the more easily repaired nerve crush.
After a nerve crush, the basal lamina around each axon/Schwann
cell unit remains intact and an axon stays within its basal lamina
tube as it grows across the injury site to reach the distal stump. It
therefore has a favorable possibility to reconnect with its original
target tissue and restore function.
In contrast, after cut, the connective tissue and basal lamina
tubes are disrupted. Regeneration units consisting of axons
accompanied by Schwann cells grow through a tissue bridge
that forms between the proximal and distal nerve stumps.
As a result of complex signaling between axons, Schwann
cells and macrophages, involving factors such as Sox2, ephrin-
B/EphB2 and TGFb, and guidance by fibroblasts and blood
vessels, axons regenerate across the bridge to meet the Schwann
cells that grow from the transected end of the distal stump
(Parrinello et al., 2010; Cattin et al., 2015; Clements et al.,
2017; reviewed in Cattin and Lloyd, 2016). Thus in cut nerves,
continuity between the proximal stump and the target is broken,
and axons are much less likely to find their way into their original
basal lamina tubes and their target tissues, compromising
proper restoration of function (Morris et al., 1972; Friede and
Bischhausen, 1980; Meller, 1987; Barrette et al., 2008). The
standard clinical treatment is to re-attach the proximal and distal
nerve stumps. Although this leaves only a microscopic gap to be
filled by a bridge, the problem of axons finding their original
basal lamina tubes remains (Witzel et al., 2005). This problem
is amplified when extensive injuries are repaired by the insertion
of a nerve graft or an artificial insert (Figure 3). The interesting
and intricate cellular interactions in the bridge region will not
be discussed here in detail (for review see Cattin and Lloyd,
2016).
It does not matter whether axons are interrupted by crush
or cut, in the distal stump the response of Schwann cells to
injury is similar. In both cases, it converts Remak and myelin
cells to repair supportive Schwann cells. The Schwann cell injury
response has two principal components and will be discussed in
terms of myelin Schwann cells only although similar principles
are likely to apply to the response of Remak cells. The reversal of
myelin differentiation represents one component. Genes coding
for Egr2 (Krox20), cholesterol-related enzymes and the myelin-
related proteins MPZ, MBP, MAG and periaxin are down-
regulated. Conversely, molecules that characterize developing
Schwann cells and adult Remak cells including, NCAM, p75NTR,
GFAP and L1 are up-regulated (reviewed in Chen et al., 2007;
Jessen and Mirsky, 2008; Martinez et al., 2015; Boerboom et al.,
2017).
The second important part of the injury response is the
appearance of a set of repair-supportive characteristics that are
not seen, or seen in a muted form, in Schwann cells in normal
mature nerves or in Schwann cells in developing nerves. This
repair component of the response includes a number of elements
(reviewed in Jessen and Mirsky, 2016).
1. Factors that promote the survival of injured neurons
and axonal elongation are up-regulated. These include
neurotrophic factors and surface molecules such as glial cell
FIGURE 3 | Main cell and tissue components of regenerating nerves. Repair cells in Bungner bands are shown in dark orange (e). Light blue shows the Schwann
cells of the tissue bridge, some of which migrate out from the distal stump (c), while others accompany regenerating axons forming regeneration units (a). Not shown
is the basal lamina that covers the Schwann cells in the proximal stump and the Bungner bands in the distal stump. The bridge Schwann cells receive important
signals from blood vessels (b), fibroblasts and macrophages (d). The position of an inserted regeneration conduit is also shown (although the cellular events within it
will depend on the nature of the conduit; with permission from Jessen and Arthur-Farraj, 2019).
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line-derived neurotrophic factor (GDNF), artemin, brain-
derived neurotrophic factor (BDNF), neurotrophin-3 (NT3),
nerve growth factor (NGF), vascular endothelial growth factor
(VEGF), erythropoietin, FGFs, pleiotrophin, N-cadherin and
p75NTR (Grothe et al., 2006; Fontana et al., 2012; Brushart
et al., 2013; reviewed in Boyd and Gordon, 2003; Chen et al.,
2007; Scheib and Höke, 2013; Wood and Mackinnon, 2015).
2. An innate immune response is activated. This involves the
upregulation of cytokines including tumor necrosis factor
α (TNFα), interleukin-1α (Il-1α), Il-1β, leukemia inhibitory
factor (LIF), monocyte chemotactic protein-1 (MCP-1) and
toll-like receptors by the Schwann cells in the distal stump
(reviewed in Martini et al., 2008; Rotshenker, 2011). This
allows repair Schwann cells to recruit macrophages and
other immune system cells such as neutrophils to the nerve,
promoting nerve regeneration in several ways. Cytokines
including Il-6 and LIF attract macrophages to the nerve
but also act directly on neurons to promote axon growth
(Hirota et al., 1996; Cafferty et al., 2001; reviewed in Bauer
et al., 2007). An additional sustained source of cytokines
are macrophages that invade nerves and ganglia. They also
promote vascularization of the nerve bridge between the
proximal and distal stumps (Barrette et al., 2008; Niemi et al.,
2013; Cattin et al., 2015). Macrophages also co-operate with
Schwann cells to degrade myelin debris (see further below;
reviewed in Hirata and Kawabuchi, 2002; Rotshenker, 2011).
3. Schwann cells proliferate and then undergo a striking about
three-fold elongation as they form the regeneration tracks,
Bungner bands, which are essential for guiding axons back
to their target areas (see further below). These structural
changes are a component of the tissue remodeling which
transforms the distal stump into a collection of regeneration
tracks (Gomez-Sanchez et al., 2017).
4. Repair cells activate mTOR-independent autophagy,
myelinophagy, to break down their myelin sheaths, which are
redundant after axonal degeneration (Gomez-Sanchez et al.,
2015; Suzuki et al., 2015; Jang et al., 2016; Brosius Lutz et al.,
2017).
THE PROPERTIES OF REPAIR CELLS
Repair Schwann Cells Show a Distinct
Molecular Profile
At least two genes, Olig 1, Shh, differentiate repair cells from
myelin and Remak cells, and also from immature Schwann
cells, and Schwann cell precursors in embryonic nerves. These
genes are highly up-regulated by c-Jun in Schwann cells of
injured nerves. These genes are distinctive markers of repair
Schwann cells because they are expressed de novo after injury
This applies also to GDNF, with the exception that this gene is
detected in embryonic Schwann cell precursors, although it is
down-regulated before birth (Lu et al., 2000; Zhou et al., 2000;
Piirsoo et al., 2010; Arthur-Farraj et al., 2012; Fontana et al., 2012;
Lin et al., 2015).
In addition, a gene expression screen found over a hundred
genes that were significantly up- or down-regulated in the
distal stump after damage, although they were not regulated
during development, since they were present at similar levels in
developing and adult uninjured nerves. The majority of these
genes were up-regulated by injury. This reveals a substantial
group of genes that are specifically activated in injured nerves,
and which are therefore candidate markers for repair cells (Bosse
et al., 2006).
Timing and the Repair Program
The different components of the repair program are not switched
on synchronously. Instead, each of them reaches peak expression
at different times after injury. For instance, protein levels of
cytokines such as Il-1β and TNFα, peak within 1 day of
injury, but are sharply lower at 3 days (Rotshenker, 2011),
autophagy is high at 5 days and reduced thereafter (Gomez-
Sanchez et al., 2015), GDNF protein levels peak at about
1 week after injury and BDNF is maximally expressed after
2–3 weeks (Eggers et al., 2010). The transcription factor c-Jun
which is an important regulator of the repair program (see
below), is activated within hours of injury, but c-Jun protein
levels continue to increase for at least 7–10 days and cellular
elongation continues for at least 4 weeks after injury (Gomez-
Sanchez et al., 2017). The repair program therefore represents
a temporal sequence of events that overlap and co-operate to
support repair.
The Elongation and Branching of Repair
Cells
One of the cardinal features of Schwann cells is their
extended morphology, a feature that is often associated with
the requirement to stretch out to cover the elongated axons.
However, Schwann cells which lose contact with degenerating
axons in the distal stump do not shorten. Rather, lineage tracing
studies have shown that loss of axonal contact triggers a striking
cellular elongation (Gomez-Sanchez et al., 2017). One week
after nerve transection without regeneration, Remak cells have
doubled in length, and 4 weeks after injury they are three-fold
longer than Remak cells in intact nerves. Similarly, myelin cells
have doubled in length by 4 weeks after injury. Loss of axonal
contact also induces the cells to branch. About 50% and 30% of
repair cells derived from Remak and myelin cells, respectively,
form branches, which are often long and lie parallel to the main
axis of the cell (Gomez-Sanchez et al., 2017; Figure 4).
This study also addressed two long-standing assumptions
about Schwann cells. First, that Remak and myelin cells
generate the cells found in the Bungner bands of injured
nerves, and second, that the Bungner band cells, in turn,
generate the myelin cells found in regenerated nerves. These
fundamental presumptions were confirmed directly using linage
tracing methods (Gomez-Sanchez et al., 2017). This allowed
repair cells from Remak cells and myelin cells to be studied
separately, and made it possible to identify the progeny of myelin
cell-derived repair cells among the cells that re-myelinate nerves
after regeneration. This revealed that re-myelination involves a
remarkable about seven-fold cell shortening, as the elongated
repair cells wrap axons to generate the typically short myelin
internodes of regenerated nerves.
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FIGURE 4 | Myelin, Remak and repair Schwann cells after genetic labeling in vivo. Shown in green are myelin and Remak cells of average length as they appear in
uninjured nerve. In red is an example of a long, branched repair cell (generated from a myelin cell), in 4 week cut nerve without reinnervation. All cells are shown to
scale. Shown also is a schematic diagram of a repair cell and the assembly of these cells to form a Bungner band enclosed by a basal lamina and containing a
regenerating axon (in blue). The electron micrograph shows a transverse section of a Bungner band (red image printed with permission from Gomez-Sanchez et al.,
2017). Scale bar: 1 µm.
Although Remak and myelin cells have sharply different
structure, they generate repair cells with broadly similar
morphology. The extremely elongated and branched structure
of these cells differentiates repair cells from other cells in
the Schwann cell lineage. This morphology also promotes
the generation of uninterrupted and robust regeneration
tracks by maximizing cell-cell overlap within each Bungner
band.
Myelin Clearance
Unlike the CNS, peripheral nerves are able to clear redundant
myelin after axonal degeneration, a feature that is widely believed
to facilitate regeneration because of the growth-inhibitory nature
of myelin (Kang and Lichtman, 2013; reviewed in Hirata and
Kawabuchi, 2002; Rotshenker, 2011). Nerves clear myelin by two
distinct mechanisms. First, Schwann cells switch from myelin
maintenance to actively breaking down their own myelin sheaths
through the mechanism of myelin autophagy (Gomez-Sanchez
et al., 2015; Suzuki et al., 2015; Jang et al., 2016; Brosius Lutz et al.,
2017). This process delivers myelin to Schwann cell lysosomes for
degradation, following internalization of myelin in the form of
myelin ovoids (Jung et al., 2011), and the formation of smaller
cytoplasmic myelin fragments. About 50% of total myelin is
thought to be broken down by Schwann cells (Perry et al., 1995).
Second, myelin debris is phagocytosed and degraded Schwann
cells and in particular by macrophages, which gradually invade
injured nerves, recruited by the repair cell cytokine expression
referred to above.
CONTROL OF REPAIR CELL GENERATION
Repair Schwann Cells Are Controlled by
Dedicated Signaling Mechanisms
A number of mechanisms take part in regulating the Schwann
cell injury response. Importantly, it has become clear that
this includes regulatory mechanisms that operate selectively
in repair cells, and have only a minor or undetectable
function in developing Schwann cells. This applies to the
transcription factors c-Jun and STAT3, which will be discussed in
subsequent sections. Regulation of histoneH3K27 trimethylation
represents another selective mechanism, which appears not
to be significantly involved in control of Schwann cell
development (Ma et al., 2016). In response to injury, however,
the activation of several injury-related genes is promoted by
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removal of the repressive histone mark H3K27 trimethylation
at their promoter regions, combined with the gain of the
active histone mark H3K4 methylation. At the same time,
the active histone mark H3K27 acetylation is lost from the
enhancers of myelin genes as their expression fades (Hung
et al., 2015; Ma et al., 2016). An important, selective role in
repair cells is also played by the tumor suppressor protein
Merlin. Schwann cell specific inactivation of Merlin has major
adverse effects on repair cell function, axonal regeneration
and re-myelination, but only minor effects on Schwann cell
development (Mindos et al., 2017). Together with the c-Jun and
STAT3, these histone methylation events described above, and
merlin, represent gene regulatory mechanisms, which selectively
control repair cells, and appear unimportant in developing
Schwann cells.
Other Signals That Control the Schwann
Cell Injury Response
Positive regulators of repair cell generation or function include
Notch (Woodhoo et al., 2009), Sox2 (Parrinello et al., 2010;
Roberts et al., 2017), gpr126 (Mogha et al., 2016), TGFb
(Morgan et al., 1994; Stewart et al., 1995; Cattin et al., 2015;
Clements et al., 2017) and ERK1/2, although its function is
complex, since it ERK1/2 activation is also required for myelin
synthesis (Harrisingh et al., 2004; Fischer et al., 2008; Newbern
et al., 2011; Napoli et al., 2012; Sheean et al., 2014; Cervellini
et al., 2018; reviewed in Monk et al., 2015; Jessen and Mirsky,
2016; Boerboom et al., 2017). The transcription factor Zeb2 is
required for normal re-myelination after injury, but appears
not to be important for the generation of repair cells (Quintes
et al., 2016; Wu et al., 2016). Toll-like receptors are involved
in up-regulation of cytokines, macrophage recruitment and
myelin clearance after injury, while the mTORC1 pathway
is also involved in myelin clearance and is needed for
effective expression of c-Jun and other repair cell genes
after injury (Boivin et al., 2007; Norrmén et al., 2018). The
significance of these proteins for axonal regeneration is not
clear.
Negative regulation of repair cells is exerted by histone
deacetylase 2 (HDAC2), which is activated after injury acts
to suppress c-Jun and delay the generation of repair cells.
Inhibition of HDAC2 therefore represents a potential route
to improve regeneration, because regeneration is accelerated
whenHDAC2 is inactivated, although re-myelination is impaired
(Brügger et al., 2017; Jacob, 2017).
Considerable attention has been paid to the potential role of
neuregulin in nerve injury. Schwann cells in transected nerves
elevate expression of ErbB2/3 receptors and neuregulin-1 I/ll
isoforms (Carroll et al., 1997; Stassart et al., 2013; Ronchi
et al., 2016). Surprisingly, however, neuregulin-1 is not involved
in injury-induced Schwann cell proliferation, and macrophage
recruitment, and myelin breakdown appears normal in nerves
without neuregulin (Atanasoski et al., 2006; Fricker et al.,
2013). Another unexpected finding is that even after removal of
neuregulin-1 from both Schwann cells and axons, re-myelination
of regenerated nerves after injury is eventually normal after
a substantial delay (Fricker et al., 2013; Stassart et al., 2013).
This contrasts with development, since neuregulin-1, expressed
by axons, is necessary for myelination by developing Schwann
cells (Birchmeier and Nave, 2008). In another deviation form
development, repair Schwann cell-derived neuregulin-1 has
a significant role in accelerating re-myelination after injury,
most likely working through an autocrine signaling loop,
while Schwann cell-derived neuregulin-1 is not important
for developmental myelination (Stassart et al., 2013). The
involvement of neuregulin-1 in the control of myelination
therefore differs between repair Schwann cells and developing
cells.
Inactivation of neuregulin-1 in axons and Schwann cells
results in slow axonal regeneration after injury. This suggests
that endogenous neuregulin signaling through ErbB2/3 receptors
in repair cells promotes the repair phenotype and enhances
the capacity of these cells to support axon growth, but direct
evidence for this mechanism of action is missing. Nevertheless,
pharmacologically enhancing neuregulin signalingmight serve as
a tool for promoting nerve repair, because enforced Schwann cell
ErbB2 expression, and exogenously applied neuregulin increase
axonal regeneration in vivo (Ronchi et al., 2013; Han et al., 2017;
reviewed in Gambarotta et al., 2013).
The Function of c-Jun in Repair Cells
The transcription factor c-Jun plays a crucial role in the Schwann
cell injury response (Jessen and Mirsky, 2016). c-Jun levels
are low in uninjured nerves, but are rapidly and strongly
elevated by injury (De Felipe and Hunt, 1994; Shy et al.,
1996). When this is prevented, by selective inactivation of
c-Jun in Schwann cells in transgenic mice (c-Jun cKO mice)
regeneration of axons and recovery of function after injury are
strikingly compromised. Uninjured nerves in these mice are
essentially normal. This indicates that c-Jun is not essential
for Schwann cell development, and that the role of this
transcription actor is restricted to controlling the response
of Schwann cells to nerve damage (Arthur-Farraj et al.,
2012).
The regeneration failure in c-Jun cKO mice is due to
the important function of c-Jun in injury-induced Schwann
cell reprogramming. c-Jun directly or indirectly affects the
expression levels of at least 172 genes of the ∼4,000 genes
that change expression in Schwann cells after injury. This gives
c-Jun significant control over both parts of the Schwann cell
injury response, de-differentiation of myelin cells and activation
of the repair program (Arthur-Farraj et al., 2012, 2017). c-Jun
helps de-differentiation, because it is needed for the normal
down-regulation of myelin genes after injury. Among these are
the genes encoding the transcription factor Egr2 (Krox20), a
master regulator of the myelin program, and the MPZ and
MBP genes. The negative gene regulation by c-Jun and its
cross-antagonistic relationship with Egr2 (Krox20) had been
studies before its importance for regeneration was revealed
and helped give rise to the idea that c-Jun, in combination
with a group of other transcriptional regulators, including
Notch, Sox2, Id2 and Pax3, functioned as negative regulators
of myelination (Kioussi et al., 1995; Parkinson et al., 2004,
2008; Le et al., 2005; Doddrell et al., 2012; Fazal et al.,
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2017; Florio et al., 2018; reviewed in Jessen and Mirsky, 2008).
Although these genes may be important for modifying the rate
or onset of myelination in developing nerves, a key role for c-
Jun-mediated gene down-regulation in vivo appears to be that of
helping to suppress myelin gene expression in adult nerves after
injury.
c-Jun also promotes the normal activation of the repair
program, which it controls in several important ways (Arthur-
Farraj et al., 2012; Fontana et al., 2012). First, in the absence
of Schwann cell c-Jun (c-Jun cKO mice), important trophic
factors and cell surface proteins that support survival and
axon growth fail to be normally upregulated. This includes
GDNF, artemin and BDNF, p75NTR and N-cadherin. Two
of these, GDNF and artemin, have been shown to be direct
c-Jun targets and have been implicated in sensory neuron
death after injury (Fontana et al., 2012). Normally some dorsal
root ganglion (DRG) sensory neurons and facial motoneurons
die after sciatic and facial nerve injury, respectively, and in
humans DRG neuron death is considered a major reason for
poor outcomes of nerve regeneration (Faroni et al., 2015).
Death of DRG neurons and facial motoneurons is greatly
increased in c-Jun cKO mice. This shows that a key function
for repair Schwann cells and c-Jun signaling is to support the
FIGURE 5 | The structure of regeneration tracks (Bungner Bands) is
controlled by Schwann cell c-Jun. Electron micrographs from the distal stump
of mouse sciatic nerve 4 weeks after transection (without regeneration).
(A) WT nerve showing classic regeneration tracks (Bands of Bungner; an
example is arrowed). (B) Distorted regeneration tracks in c-Jun cKO nerve,
containing irregular and flattened cellular profiles (with permission from
Arthur-Farraj et al., 2012). Scale bar: 1 µm.
survival of injured neurons. Second, the regeneration tracks
formed by denervated Schwann cells without c-Jun have a
disorganized structure (Figure 5). In culture, c-Jun is needed for
the typical narrow, bi/tripolar Schwann cell morphology, since
c-Jun-negative cells tend to be flat and sheet-forming. Similarly,
in vivo, the repair Schwann cells within the regeneration tracks
show grossly abnormal morphology when viewed in transverse
electron micrograph sections. c-Jun appears to be necessary for
the conversion of the complex and sheath-like structure of the
myelin cells to the narrow, rod-like and branched structure
of repair cells that is required for the formation of normal
regeneration tracks. Third, c-Jun promotes myelinophagy, and
c-Jun cKO nerves show a substantial delay in breakdown
of myelin (Arthur-Farraj et al., 2012; Gomez-Sanchez et al.,
2017).
Thus, c-Jun exerts a broad control over the Schwann cell
injury response, and thereby neuronal survival and regeneration.
It is therefore of interest that in two important situations where
repair cells fail, namely chronic denervation and aging, c-Jun
levels in these cells are reduced. This is discussed in ‘‘Nerve Injury
Activates Epithelial Mesenchymal Transition (EMT) Genes’’
section below.
NERVE INJURY ACTIVATES EPITHELIAL
MESENCHYMAL TRANSITION (EMT)
GENES
Recent gene screen studies suggest that the generation of repair
cells involves the activation of a process related to epithelial
mesenchymal transitions (EMTs; Arthur-Farraj et al., 2017;
Clements et al., 2017). RNA-Seq of distal nerve stumps 7 days
after injury show enrichment for EMT mRNAs and miRNAs.
This includes down-regulation of RNAs that are linked to
mesenchymal-epithelial transition (MET), and up-regulation of
RNAs associated with EMT. Enrichment for EMT genes was
also shown in more detailed experiments using FACs to sort
td-tomato labeled Schwann cells from injured nerves (Clements
et al., 2017). This study also showed that EMT activation
was strongest in the Schwann cells the tissue bridge, where
arguably tissue remodeling is more radical than in the distal
stump.
Typically, EMT-like processes involve also an increase in
stemness, namely the activation of genes associated with stem
cells (Fabregat et al., 2016; Liao and Yang, 2017). This is
also seen in injured nerves, where the generation of repair
cells is accompanied by activation of the Myc stemness and
Core pluripotencymodules and suppression of polycomb-related
factors (Clements et al., 2017).
In many tissues, the combined activation of EMT and
stemness is associated with increased cellular motility,
proliferation, morphological flexibility, tissue remodeling,
and the loosening up of differentiation states (Nieto et al.,
2016; Forte et al., 2017). These events are key features of the
response of many tissues to injury. Not surprisingly, therefore,
the activation of EMT and stemness programs have now been
established as a key physiological response to injury in various
tissues.
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The demonstration of EMT/stemness activation in Schwann
cells of injured nerves brings the nerve injury response in
line with injury responses in many other systems. It adds an
important new component to our understanding of the injury
response. In particular, the loosening of differentiation states
associated with increased stemness is consistent with the notion
that nerve injury triggers a shift in Schwann cell differentiation
state from myelin and Remak phenotypes to a Schwann cell state
specialized to promote repair.
WHY DOES REGENERATION FAIL?
In the light of the radical, adaptive injury response of neurons
and Schwann cells, which in many types of rodent experiments
results in effective nerve repair, why is it that the clinical
outcome after nerve injury in humans is generally poor? This
paradox of PNS repair can be explained by a number of factors,
including the hindrance to axon growth provided by the injury
site and the difficulty of getting large numbers of axons from
the proximal to the distal stump, misrouting of axons resulting
in re-innervation errors, and the presence of growth-inhibiting
extracellular matrix. Perhaps the most difficult problems arise
from the relatively slow growth of axons. Because of this, most
human nerve injuries involve chronic denervation of the more
distal parts of damaged nerves and of the target tissues such as
muscle. This results in target atrophy, while neurons gradually
die and surviving neurons may fail to sustain their capacity
to regenerate axons during the extended period required for
repair (Höke, 2006a; Sulaiman and Gordon, 2013; Patel et al.,
2018).
Here, we will consider another major issue in regeneration
failure. This is the fact that the nerve stump distal to transection
gradually loses the ability to support the growth of regenerating
axons during chronic denervation. This has been shown in
a number of studies, most of which represent cross-suturing,
typically involving the suturing of acutely transacted tibial nerve
to the distal stump of the common peroneal nerve, which
had be transected either acutely, the control condition, or at
different times up to 6 months previously. Other experiments for
addressing the same question have studied regeneration through
nerve grafts, where the graft is obtained from nerves that have
been denervated previously for various lengths of time. All of the
experiments agree that transected nerve stumps retain full or only
mildly reduced capacity for supporting regeneration for about
1 month (Li et al., 1997; Sulaiman and Gordon, 2000; Kou et al.,
2011; Jonsson et al., 2013). By 2 months, regeneration support
remains unchanged in some studies (Li et al., 1997), although
other reports show it reduced by about 40%–50% (Sulaiman
and Gordon, 2000; Kou et al., 2011). At 3 months regeneration
support is further diminished and reduced to very low levels by
6 months (Li et al., 1997; Sulaiman and Gordon, 2002; Gordon
et al., 2011; Jonsson et al., 2013; see however Rönkkö et al.,
2011).
While these experiments were carried out on rats, we find that
also inmice, the capacity of distal stumps to support regeneration
is reduced by about 50% after 2.5 months of chronic denervation
(Wagstaff et al., 2017).
IS THE FAILURE OF DISTAL STUMPS TO
SUPPORT GROWTH DUE TO LACK OF
SCHWANN CELLS?
The deterioration in the capacity of chronically denervated
stumps to support regeneration could result from two separate
factors: gradual reduction in Schwann cell numbers, or the
fading of the repair phenotype of cells still present in the nerve.
Both of these factors could in turn be influenced by signals
from macrophages that invade injured nerves and are initially
present in large numbers that decline with time. The question of
whether Schwann cell number is a key factor raises two additional
ones. First, what is known about Schwann cell numbers in
chronically transacted nerves? Second, are variations in Schwann
cell numbers within the range seen in cut nerves likely to affect
regeneration?
While it is long established that nerve injury triggers a
wave of Schwann cell proliferation, there is surprisingly little
quantitative information on Schwann cell numbers in cut nerves
after injury. Cell counts using electron microscopy show that
2 weeks after cut the number of Schwann cells in mouse sciatic
nerve has risen about 2.5-fold compared to uninjured nerves
and remains similar at 1 and 1.5 months (Wagstaff et al., 2017),
Using S100 to identify Schwann cells in the cut sciatic nerve of
rats show 3–4-fold increase at 1–2 weeks with little change at
1.5 months (Siironen et al., 1994). These workers also report a
sharp drop between 1.5 and 2 months, but since S100 is present
at reduced levels after injury, these figures might overestimate
the reduction in Schwann cell number (Siironen et al., 1994).
Another study also using S100 indicates that Schwann cell
numbers at 2.5 months remains 2–3-fold that in uncut nerves
(Salonen et al., 1988). Our data from mouse nerves show a drop
of about 30% between 2 weeks and 2.5 months (Wagstaff et al.,
2017).
A study employing a more indirect method involving
counting of the number of cells obtained by enzymatic
dissociation of nerves at different times after nerve cut without
innervation, concluded that the number of Schwann cells drops
by about 30% between 1 and 2 months with little change at
3 and 4 months (Li et al., 1998). The number of cells that can
be isolated from nerves after 6 months of chronic denervation is
only 10%–15% of that obtained at 4 weeks (Li et al., 1998; Jonsson
et al., 2013).
Although the data are limited and not always consistent, the
above suggests that 2–3 months after chronic denervation, a time
when growth support by the distal stump is significantly reduced,
the number of Schwann cells has dropped at most by about
30%–50% from the high cell number seen 1–4 weeks after injury.
This would mean that the number of cells at 2–3 months remains
substantially higher than the number in uninjured nerves.
Is it likely that this fall from peak cell numbers accounts for the
reduction in regenerative support during chronic denervation?
The answer to this question depends on the weight is put
on the reports discussed below that imply that regeneration
remains normal in nerves where injury-induced increase in
Schwann cell numbers is prevented, and cell numbers in the
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distal stump therefore remain similar to those in uninjured
nerves.
DOES NERVE REGENERATION DEPEND
ON SCHWANN CELL PROLIFERATION?
It is a common view that Schwann cell proliferation and
expansion in Schwann cell numbers in injured nerves is
required for regeneration (Hall and Gregson, 1977; Hall, 2005).
Recent genetic approaches to specifically inhibit Schwann cell
proliferation suggest, however, that this may not be the case.
Injury-induced Schwann cell proliferation depends on cyclin D1,
although this protein is not important for proliferation during
development. Nerves in D1−/− mice therefore develop normally,
but Schwann cell proliferation after injury is blocked. Perhaps
surprisingly, regeneration appears not to markedly affected in
these mice (Kim et al., 2000; Atanasoski et al., 2001; Yang et al.,
2008).
DETERIORATION OF REPAIR CELLS: AN
IMPORTANT REASON FOR
REGENERATION FAILURES
Since Schwann cell numbers after 2–3 months of chronic
denervation are likely to remain at least double that in uninjured
nerves, and in view of the experiments on cyclin1−/− mice
outlined above, it seems that lack of Schwann cells is unlikely
to be the major reason for the reduction in growth support
provided by 2–3 month chronically denervated stumps, although
at later times ongoing reduction in cell number will eventually
be significant. This suggests that the deterioration of repair cells
is a two-stage process involving, first, surviving cells gradually
down-regulating their repair phenotype, followed by death of
cells that have by that time lost most of their regeneration-
supportive properties. There is in fact ample evidence for
such fading of the repair cell phenotype, manifest in reduced
expression of neuron-supportive trophic factors during chronic
denervation, including GDNF, BDNF, NT3 and NGF (Eggers
et al., 2010; reviewed in Boyd and Gordon, 2003; Höke and
Brushart, 2010).
Thus, the fading of the repair phenotype, combined in the
long run with dwindling cell numbers, are likely to be the twin
reasons for reduced growth support provided by chronically
denervated stumps. It is therefore important to identify factors
that control the long-termmaintenance of repair cells, sustain the
expression of repair supportive genes and support cell survival.
SIGNALS THAT MAINTAIN REPAIR CELLS
While there are as yet surprisingly few studies on this important
topic, two transcription factors, STAT3 and c-Jun have recently
been shown to have a role in repair cell maintenance (Benito
et al., 2017; Wagstaff et al., 2017). Activation of Schwann
cell STAT3 is triggered by injury, and largely sustained in
long-term denervated repair cells (Sheu et al., 2000). Genetic
inactivation of STAT3 in these cells results in decreased autocrine
Schwann cell survival signaling and a striking loss of Schwann
cells from chronically denervated stumps. Loss of STAT3 also
reduces the expression of repair cell markers, including GDNF,
BDNF and Shh, during long-term denervation (Benito et al.,
2017). Inactivation of Schwann cell STAT3 does, however, not
significantly affect nerve development. The important role of
STAT3, therefore, is to acts as a brake on the deterioration of
repair cells in chronically denervated adult nerves.
Unlike STAT3, c-Jun levels in Schwann cells decline
significantly during long-term denervation, in tandem with
the fading of the repair phenotype, reduced cell numbers,
and reduced capacity to support regeneration. Significantly,
the ability of long-term denervated repair cells to support
regeneration can be restored to control levels by genetically
enhancing c-Jun expression in these cells to levels similar to
those in short-term denervated nerve stumps (Fazal et al.,
2017; Wagstaff et al., 2017). This raises the possibility that
the deterioration of chronically denervated repair cells is to
a significant extent caused by a failure to sustain high c-Jun
levels.
Aging, like chronic denervation, is accompanied by a marked
reduction in the rate of nerve regeneration (Verdú et al., 2000;
Painter, 2017). Using rodent models, this has been traced
primarily to age-related deterioration of repair Schwann cells,
since repair cells from older animals show reduced expression of
repair cell markers and reduced ability to support axon growth
(Painter et al., 2014). Many of the abnormally expressed genes
are c-Jun regulated, and c-Jun activation after injury is also
significantly reduced in older animals. These observations have
implicated dysregulation of Schwann cell c-Jun in the age-related
deterioration of nerve repair (Painter et al., 2014; Wagstaff et al.,
2017). A support for this suggestion comes from experiments
on transgenic animals in which c-Jun expression in injured old
nerves has been elevated to levels similar to those of injured
young nerves. This correction of Schwann cell c-Jun levels is
sufficient to correct the age-related regeneration deficit, and
accelerate the rate of axonal regeneration to that seen in young
animals (Wagstaff et al., 2017). Therefore, the inability of repair
Schwann cells in older animals to elevate c-Jun to high levels
may be a significant factor in the age-related failure of nerve
repair.
CONCLUSIONS
The key driver of nerve regeneration, apart from the neurons
themselves, are the denervated Schwann cells that make up
the regeneration tracks, Bungner bands, that occupy nerves
distal to the injury site. These repair Schwann cells are
adapted to meet the particular needs that arise in injured adult
nerves. They differ from other Schwann cells, having separate
transcriptional and epigenetic mechanisms, distinct morphology
and molecular profile, in addition to carrying out a set of
functions, comprising the repair program, which support nerve
regeneration.
The realization that these cells possess distinct properties and
cell-type specific control mechanisms is a useful step forward. It
will help to focus future work on learning how to manipulate
these particular cells, how to amplify their repair-supportive
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functions, and how prevent their deterioration in older age and
during the prolonged periods required for axonal regeneration in
human nerves.
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